147 related articles for article (PubMed ID: 18336841)
1. Bombesin marine toxin conjugates inhibit the growth of lung cancer cells.
Moody TW; Pradhan T; Mantey SA; Jensen RT; Dyba M; Moody D; Tarasova NI; Michejda CJ
Life Sci; 2008 Apr; 82(15-16):855-61. PubMed ID: 18336841
[TBL] [Abstract][Full Text] [Related]
2. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
3. ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.
Moody TW; Mantey SA; Moreno P; Nakamura T; Lacivita E; Leopoldo M; Jensen RT
Peptides; 2015 Feb; 64():55-61. PubMed ID: 25554218
[TBL] [Abstract][Full Text] [Related]
4. AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.
Moody TW; Tashakkori N; Mantey SA; Moreno P; Ramos-Alvarez I; Leopoldo M; Jensen RT
Front Endocrinol (Lausanne); 2017; 8():176. PubMed ID: 28785244
[TBL] [Abstract][Full Text] [Related]
5. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
Moody TW; Leyton J; Garcia-Marin L; Jensen RT
Eur J Pharmacol; 2003 Aug; 474(1):21-9. PubMed ID: 12909192
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
Moody TW; Sun LC; Mantey SA; Pradhan T; Mackey LV; Gonzales N; Fuselier JA; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2006 Sep; 318(3):1265-72. PubMed ID: 16766720
[TBL] [Abstract][Full Text] [Related]
7. A structure function study of C-terminal extensions of bombesin.
Mervic M; Moody TW; Komoriya A
Peptides; 1991; 12(5):1149-51. PubMed ID: 1666185
[TBL] [Abstract][Full Text] [Related]
8. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).
Darker JG; Brough SJ; Heath J; Smart D
J Pept Sci; 2001 Nov; 7(11):598-605. PubMed ID: 11763364
[TBL] [Abstract][Full Text] [Related]
10. JMV641: a potent bombesin receptor antagonist that inhibits Swiss 3T3 cell proliferation.
Azay J; Gagne D; Devin C; Llinares M; Fehrentz JA; Martinez J
Regul Pept; 1996 Aug; 65(1):91-7. PubMed ID: 8876041
[TBL] [Abstract][Full Text] [Related]
11. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
[TBL] [Abstract][Full Text] [Related]
12. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells.
Moody TW; Fuselier J; Coy DH; Mantey S; Pradhan T; Nakagawa T; Jensen RT
Peptides; 2005 Sep; 26(9):1560-6. PubMed ID: 16112393
[TBL] [Abstract][Full Text] [Related]
13. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
Moody TW; Staley J; Zia F; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
[TBL] [Abstract][Full Text] [Related]
14. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
[TBL] [Abstract][Full Text] [Related]
15. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
[TBL] [Abstract][Full Text] [Related]
16. The development of VIP-ellipticine conjugates.
Moody TW; Czerwinski G; Tarasova NI; Moody DL; Michejda CJ
Regul Pept; 2004 Dec; 123(1-3):187-92. PubMed ID: 15518911
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
[TBL] [Abstract][Full Text] [Related]
18. GRP receptors are present in non small cell lung cancer cells.
Moody TW; Zia F; Venugopal R; Fagarasan M; Oie H; Hu V
J Cell Biochem Suppl; 1996; 24():247-56. PubMed ID: 8806107
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor.
De K; Banerjee I; Sinha S; Ganguly S
Peptides; 2017 Mar; 89():17-34. PubMed ID: 28088445
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
